About DAXOR CORPORATION
Daxor is a company that develops and provides Blood Volume Analysis (BVA™), a diagnostic tool used to measure blood volume with precision, aiding in fluid management across various medical conditions. The technology is used in critical care, chronic disease management, and is reimbursed by public and private payers.
Blood Volume Analysis (BVA™) using indicator dilution techniqueAutomated quantification of total blood, plasma, and red cell volumes with 95% accuracyIntegration into existing clinical workflows for actionable dataReimbursement by public and private payers for inpatient and outpatient useProvides diagnostic clarity for complex conditions like sepsis, ARDS, and heart failure
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| PREVENTIVE MAINTENANCE AND REPAIR FOR DAXOR BVA-100 BLOOD VOLUME ANALYZER. | Department of Veterans Affairs | $15K | |
| 59 MDW/ST SBIR II TACFI. DEVELOP AND VALIDATE HARDWARE AND METHOD FOR THE BVA-200F DIAGNOSTIC. | Department of Defense | $1.9M | |
| DHA SBIR PH II H2S-0039 (MONTHS 1-23) | Department of Defense | $1.6M | |
| Federal contract award | Department of Defense | $1.1M | |
| FAR FORWARD AND EN ROUTE DECISION ASSIST IN THE TREATMENT OF HEMORRHAGE | Department of Defense | $750K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to DAXOR CORPORATION right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.